Historical Valuation
Klotho Neurosciences Inc (KLTO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Klotho Neurosciences Inc (KLTO) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.34
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Klotho Neurosciences Inc (KLTO) has a current Price-to-Book (P/B) ratio of 2.26. Compared to its 3-year average P/B ratio of 5601.80 , the current P/B ratio is approximately -99.96% higher. Relative to its 5-year average P/B ratio of 5632.22, the current P/B ratio is about -99.96% higher. Klotho Neurosciences Inc (KLTO) has a Forward Free Cash Flow (FCF) yield of approximately -23.97%. Compared to its 3-year average FCF yield of -15.29%, the current FCF yield is approximately 56.75% lower. Relative to its 5-year average FCF yield of -13.65% , the current FCF yield is about 75.59% lower.
P/B
Median3y
5601.80
Median5y
5632.22
FCF Yield
Median3y
-15.29
Median5y
-13.65
Competitors Valuation Multiple
AI Analysis for KLTO
The average P/S ratio for KLTO competitors is 0.02, providing a benchmark for relative valuation. Klotho Neurosciences Inc Corp (KLTO.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for KLTO
1Y
3Y
5Y
Market capitalization of KLTO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of KLTO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is KLTO currently overvalued or undervalued?
Klotho Neurosciences Inc (KLTO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Klotho Neurosciences Inc (KLTO) is between to according to relative valuation methord.
What is Klotho Neurosciences Inc (KLTO) fair value?
KLTO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Klotho Neurosciences Inc (KLTO) is between to according to relative valuation methord.
How does KLTO's valuation metrics compare to the industry average?
The average P/S ratio for KLTO's competitors is 0.02, providing a benchmark for relative valuation. Klotho Neurosciences Inc Corp (KLTO) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Klotho Neurosciences Inc (KLTO) as of Jan 10 2026?
As of Jan 10 2026, Klotho Neurosciences Inc (KLTO) has a P/B ratio of 2.26. This indicates that the market values KLTO at 2.26 times its book value.
What is the current FCF Yield for Klotho Neurosciences Inc (KLTO) as of Jan 10 2026?
As of Jan 10 2026, Klotho Neurosciences Inc (KLTO) has a FCF Yield of -23.97%. This means that for every dollar of Klotho Neurosciences Inc’s market capitalization, the company generates -23.97 cents in free cash flow.
What is the current Forward P/E ratio for Klotho Neurosciences Inc (KLTO) as of Jan 10 2026?
As of Jan 10 2026, Klotho Neurosciences Inc (KLTO) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Klotho Neurosciences Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Klotho Neurosciences Inc (KLTO) as of Jan 10 2026?
As of Jan 10 2026, Klotho Neurosciences Inc (KLTO) has a Forward P/S ratio of 0.00. This means the market is valuing KLTO at $0.00 for every dollar of expected revenue over the next 12 months.